Alzheimer’s Database
The current version of the database includes clinical safety and efficacy information on all symptomatic drugs as well as newer AD drugs currently approved or in development for Alzheimer’s Disease (AD).
The clinical outcomes database contains information from 116 trials, representing 291 unique treatment arms and about 32,408 patients. There are a total of 7249 rows in the database.
Click on the link to download our Alzheimer’s Database Information Sheet
